Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Thom

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
International Journal of Cardiology|November 21, 2007
South Asian men have different patterns of coronary artery disease when compared with European menTherese Tillin, Harshil Dhutia, John Chambers, et al.
European Journal of Preventive Cardiology|April 25, 2017
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high riskMelvin Lafeber, Wilko Spiering, Frank Lj Visseren, et al.
BMJ Open|June 25, 2013
INterpreting the Processes of the UMPIRE Trial (INPUT): protocol for a qualitative process evaluation study of a fixed-dose combination (FDC) strategy to improve adherence to cardiovascular medicationsAbdul Salam, Frances Stewart, Kavita Singh, et al.
European Journal of Preventive Cardiology|October 6, 2012
Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and EuropeSimon Thom, Jane Field, Neil Poulter, et al.
Plos Medicine|October 19, 2016
Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three StudiesReecha Sofat, Jackie A Cooper, Meena Kumari, et al.
American Heart Journal|January 21, 2014
TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocolAbdul Salam, Ruth Webster, Kavita Singh, et al.
International Journal of Cardiology|April 7, 2018
Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trialKavita Singh, Catriona Crossan, Tracey-Lea Laba, et al.
Diabetes Care|February 27, 2009
Serum amyloid A, C-reactive protein, and retinal microvascular changes in hypertensive diabetic and nondiabetic individuals: an Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) substudyChristoph Stettler, Nicholas Witt, Robyn J Tapp, et al.
JAMA|September 5, 2013
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trialSimon Thom, Neil Poulter, Jane Field, et al.
Hypertension (Dallas, Tex. : 1979)|November 13, 2013
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudyAnthony J Barron, Alun D Hughes, Andrew Sharp, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Cardiology|November 21, 2007
South Asian men have different patterns of coronary artery disease when compared with European menTherese Tillin, Harshil Dhutia, John Chambers, et al.
European Journal of Preventive Cardiology|April 25, 2017
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high riskMelvin Lafeber, Wilko Spiering, Frank Lj Visseren, et al.
BMJ Open|June 25, 2013
INterpreting the Processes of the UMPIRE Trial (INPUT): protocol for a qualitative process evaluation study of a fixed-dose combination (FDC) strategy to improve adherence to cardiovascular medicationsAbdul Salam, Frances Stewart, Kavita Singh, et al.
European Journal of Preventive Cardiology|October 6, 2012
Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and EuropeSimon Thom, Jane Field, Neil Poulter, et al.
Plos Medicine|October 19, 2016
Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three StudiesReecha Sofat, Jackie A Cooper, Meena Kumari, et al.
American Heart Journal|January 21, 2014
TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocolAbdul Salam, Ruth Webster, Kavita Singh, et al.
International Journal of Cardiology|April 7, 2018
Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trialKavita Singh, Catriona Crossan, Tracey-Lea Laba, et al.
Diabetes Care|February 27, 2009
Serum amyloid A, C-reactive protein, and retinal microvascular changes in hypertensive diabetic and nondiabetic individuals: an Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) substudyChristoph Stettler, Nicholas Witt, Robyn J Tapp, et al.
JAMA|September 5, 2013
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trialSimon Thom, Neil Poulter, Jane Field, et al.
Hypertension (Dallas, Tex. : 1979)|November 13, 2013
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudyAnthony J Barron, Alun D Hughes, Andrew Sharp, et al.
Pageof 6